Health · Medical Research · 14 hrs ago
Cancer trial participants received a median $2,128 for nonmedical costs
Cancer clinical trial participants were reimbursed a median $2,128 for nonmedical expenses, according to new research.
These costs are expenses other than medical care linked to taking part in a trial.
The financial burden can depend on socioeconomic and logistical factors, the analysis found.
That means the costs of participation may vary with people’s circumstances and the practical demands of joining a trial.
The researchers say better reimbursement programs are needed to make access to cancer trials more equitable.
They also say improved reimbursement could help participants stay in trials.
The analysis was published in the journal CANCER, and no specific policy changes were announced.
Cancer clinical trial participants received a median of $2,128 for nonmedical expenses.
Research says participation can create financial burdens shaped by socioeconomic and logistical factors.
The analysis says better reimbursement programs are needed to improve equitable access to and retention in cancer trials.
The analysis was published online by Wiley in CANCER on November 9, 2026.
- Who
- Participants in cancer clinical trials.
- What
- They received a median of $2,128 for nonmedical expenses.
- When
- The analysis was published on November 9, 2026.
- Where
- Not stated.
- Why
- Reimbursement is intended to address financial burdens and improve equitable access to and retention in trials.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Median reimbursement
- $2,128
- Study focus
- Nonmedical expenses for cancer clinical trial participants
- Journal
- CANCER
- Publication date
- November 9, 2026